AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received extended indication approval from the Drugs Controller General of India (DGCI) for its drug, Dapagliflozin in the treatment of heart failure (HF) in adults. Th...